» Articles » PMID: 17943134

The Impact of a Negligent G2/M Checkpoint on Genomic Instability and Cancer Induction

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2007 Oct 19
PMID 17943134
Citations 272
Authors
Affiliations
Soon will be listed here.
Abstract

DNA damage responses (DDR) encompass DNA repair and signal transduction pathways that effect cell cycle checkpoint arrest and/or apoptosis. How DDR pathways respond to low levels of DNA damage, including low doses of ionizing radiation, is crucial for assessing environmental cancer risk. It has been assumed that damage-induced cell cycle checkpoints respond to a single double strand break (DSB) but the G2/M checkpoint, which prevents entry into mitosis, has recently been shown to have a defined threshold of 10-20 DSBs. Here, we consider the impact of a negligent G2/M checkpoint on genomic stability and cancer risk.

Citing Articles

Proteogenomic characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis.

Liu Y, Yang Z, Pu J, Zhong J, Khoo U, Su Y Clin Transl Med. 2025; 15(3):e70261.

PMID: 40038875 PMC: 11879901. DOI: 10.1002/ctm2.70261.


DNA damage checkpoints balance a tradeoff between diploid- and polyploid-derived arrest failures.

Fujimaki K, Jambhekar A, Lahav G bioRxiv. 2025; .

PMID: 39990415 PMC: 11844538. DOI: 10.1101/2025.02.14.638318.


G2M-checkpoint related immune barrier structure and signature for prognosis and immunotherapy response in hepatocellular carcinoma: insights from spatial transcriptome and machine learning.

Chen X, Wu S, He H, Tang J, Zhong Y, Fang H J Transl Med. 2025; 23(1):202.

PMID: 39966861 PMC: 11837653. DOI: 10.1186/s12967-024-06051-4.


Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase.

Xiao B, Wu S, Tian Y, Huang W, Chen G, Luo D Cell Biol Toxicol. 2024; 41(1):17.

PMID: 39725720 PMC: 11671434. DOI: 10.1007/s10565-024-09962-6.


The Tumour Microenvironment and Epigenetic Regulation in Pathogenic Variant-Associated Breast Cancers.

Tay J, Ho J, Cheo F, Iqbal J Cancers (Basel). 2024; 16(23).

PMID: 39682099 PMC: 11639800. DOI: 10.3390/cancers16233910.